Stowers Institute Received Funding for Protein Research
Researchers in Kansas City will use new AI models to study protein behavior linked to degenerative brain diseases.
Updated on Oct. 10, 2026 in Diseases — General
Live Poll
Should medical researchers prioritize using artificial intelligence to detect neurodegenerative diseases earlier?
The Stowers Institute for Medical Research has secured $4.1 million in funding to help build a massive dataset on how proteins self-assemble. This work, part of a $28.6 million project, aims to improve how artificial intelligence predicts protein dysfunction in conditions like frontotemporal lobar degeneration.
Why it matters
Current artificial intelligence models lack the high-quality data necessary to accurately predict the behavior of disordered proteins. By mapping these interactions, researchers hope to create a foundation for developing new therapeutics and detection methods for neurodegenerative diseases.
The project will leverage Distributed Amphifluoric FRET (DAmFRET) technology to generate over 10 billion measurements of 50,000 proteins. This foundational data will be collected from yeast cells to train AI models in a project that currently spans an initial 24-month phase.
The players
Stowers Institute for Medical Research
A Kansas City-based biomedical research organization focused on fundamental biology and the mechanisms of disease.
ARPA-H
The Advanced Research Projects Agency for Health is a federal agency that funds high-risk, high-reward biomedical innovation.
Randal Halfmann
A researcher at the Stowers Institute who specializes in the mechanics of protein aggregation and amyloid formation.
The details
The NATIVE-ID project utilizes DAmFRET technology to observe protein self-assembly in living yeast cells, capturing how proteins aggregate in real time. By studying 50,000 proteins, the team aims to build a comprehensive map of protein behavior. This data acts as a training set for artificial intelligence to identify when proteins misfold or clump, a biological process known to trigger various degenerative disorders.
Timeline
2015: Randal Halfmann joined the Stowers Institute.
2018: The DAmFRET technology was developed.
2023: Halfmann's lab determined the structure of amyloid formation.
October 9, 2026: The research project was announced.
Health Landscape
The NATIVE-ID project marks a departure from traditional drug discovery by focusing on the large-scale computational prediction of protein dynamics. This work situates itself within a growing trend of integrating biophysical data with AI to decode complex disease pathways.
This project focuses on building foundational models and datasets, meaning it does not currently change existing diagnostic or treatment options for patients. While the work is early-stage, it represents an important shift in how scientists approach neurodegenerative conditions that are worth discussing with your doctor.
The takeaway
Large-scale protein research is key to eventually creating better tools for diagnosing neurodegenerative conditions. As this field advances, follow updates on how new AI technologies are shortening the timeline for identifying potential therapeutic interventions.
Further reading
Learn more about the latest research and clinical developments in our Diseases — General section.
Live Poll
Should medical researchers prioritize using artificial intelligence to detect neurodegenerative diseases earlier?
